Delivery Order SPE2DB22D1106-SPE2DB25FEDB0

Award Date 3/13/25
Potential Completion Date 3/14/25
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,358.10 firm fixed-price delivery order is for the supply of Veltassa 8.4 GM powder packets, a specialty pharmaceutical product. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets. The contract has a ceiling value of $2,391.82 and a completion date of February 6, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,775.46, is for the delivery of 4,564,016,588 packets of Veltassa 8.4 GM Powder, a specialty medication. The contract has a period of performance through March 20, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,664.28 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,840.04 firm fixed-price delivery order contract is for the supply of 4,565,283,546 packets of the medication Veltassa 8.4 GM Powder. The contract has a completion date of July 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The $1,936.65 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024. The contract has an ultimate completion date of October 25, 2024 and is designated as a Delivery Order with no set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,541.68, is for the supply of Veltassa 8.4 GM powder packets to support federal healthcare programs. The contract has a firm fixed-price pricing type and an ultimate completion date of August 19, 2024. This order is part of AmerisourceBergen's broader Indefinite Delivery Contract with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Veltassa 8.4 GM powder packets. The firm-fixed-price contract has a ceiling value of $12,212.80 and a period of performance through March 15, 2024. This order is placed under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of VELTASSA 8.4 GM POWDER PACKET 30S, a specialty medication. The contract has a ceiling value of $3,535.73 and a completion date of December 2, 2022. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VELTASSA 8.4 GM POWDER PACKET 30S. The contract has a ceiling value of $2,527.47 and a completion date of February 2, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEDB0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Veltassa 8.4 GM powder packets. The contract has a ceiling value of $7,740.07 and a performance period through March 14, 2025. It is a firm-fixed-price contract type.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order is one of the orders placed against this IDC.

This contract award does not have a set-aside designation, indicating open competition.

Generated 6/12/25, 10:02 AM